Publication at First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové |
2021
Abstract
In connection with the possibility of availability of the medicinal substance bamlanivimab for use in the Czech Republic At the request of the Minister of Health of the Czech Republic, a working group was set up representing professional societies in order to formulate principles for the effective use of bamlanivimab in patients with COVID-19. The working group formulated an opinion at its meeting.